Dairy Product Directory

CYDETIN 

Keep Cydectin out of reach of children.
When used according to label directions, neither a pre-slaughter withdrawal period nor a milk discard time is required. Do not use in calves to be processed for veal. For external use only. Do not apply to areas of skin with mange scabs, skin lesions, mud or manure, Cydectin Pour-On is not recommended for use in species other than cattle.

FOR ALL PRODUCTS: The label contains complete use information, including cautions and warnings. Always read, understand and follow the label, and use directions.

Click to download Cydectin Dewormer Product Label.

MICOTIL 300

INDICATIONS: 

Micotil is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. It is indicated for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica. 

Important Safety Information (ISI)

Before using this product, it is important to read the entire product insert, including the boxed human warning. For full prescribing information call 1 888 545 5973 or visit
www.elancolabels.com/us/micotil-300.

HUMAN WARNING: Not for human use. Injection of this drug in humans has been associated with fatalities. Keep out of reach of children. Administer only with a tube-fed safety syringe. Do not use in automatically powered syringes, single-use syringes, or other delivery devices. Exercise extreme caution to avoid accidental self-injection. In case of human injection, consult a physician immediately and apply ice or cold pack to injection site while avoiding direct contact with the skin. Emergency medical telephone numbers are 1-800-722-0987 or 1-800-428-4441. Avoid contact with skin, eyes, or mucous membranes.

Micotil is available only by prescription. Micotil must be used with the quick-fit connector and tube-fed safety syringe included to avoid accidental self-injection. Contact Elanco or your distributor for this equipment if needed. For subcutaneous injection in cattle and sheep only; do not administer intravenously. Injection of this antibiotic has been shown to be fatal in swine and non-human primates and may be fatal in horses, goats, and other species. Not for use in use in lactating dairy cattle 20 months of age or older. Use in lactating dairy cattle or sheep may cause milk residues. Injection site swelling and inflammation, lameness, collapse, anaphylaxis/anaphylactoid reactions, decreased food and water consumption, and death have been reported in cattle. Micotil has a pre-slaughter withdrawal time of 42 days. See package insert for full prescribing information.

BAYTRIL 100 

INDICATIONS: 

Cattle Indications:  
Single-Dose Therapy: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. 
Multiple-Day Therapy: Baytril 100 is indicated for the treatment of BRD associated with M. haemolytica, P. multocida and H. somni in beef and non-lactating dairy cattle.  

Important Safety Information (ISI)

Cattle

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian and prohibits the extra-label use of this drug in food-producing animals.

Not for human use. Keep out of reach of children. Avoid contact with eyes and skin. Individuals with a history of hypersensitivity to quinolones should avoid this product. Not for use in female dairy cattle 20 months of age or older, including dry dairy cows, and veal calves; a withdrawal period has not been established for this product in pre-ruminating calves. Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. Baytril 100 has a pre-slaughter withdrawal time of 28 days for cattle. See package insert for additional safety information. 

BOVAER

CAUTION:  Do not feed undiluted. For use in feed for lactating dairy cows only.

Directions for Use: Thoroughly mix Bovaer 10 into a total mixed ration at 540‐720 g/ton of complete feed (100% dry matter basis) to provide 27.2‐36.3 mg 3‐nitrooxypropanol per pound (60‐80 mg per kilogram) of dry matter intake.  Feed continuously to lactating dairy cows. 

ENCORE

DIRECTIONS FOR USE:

Administer one dose in the ear subcutaneously according to label directions.

Click to download Bovaer Product Label

INCREXXA

INDICATIONS: 
Beef and Non-Lactating Dairy Cattle:  Increxxa is indicated for the treatment of bovine respiratory disease (BRD) and control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis; and for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii. 
Suckling Calves, Dairy Calves and Veal Calves: Increxxa is indicated for the treatment of BRD associated with M. haemolytica, P. multocida, H. somni, and M. bovis.

Important Safety Information (ISI)

Increxxa is available only by prescription. Not for human use. Keep out of reach of children. Do not use in animals previously found to be hypersensitive to the drug. Not for use in chickens or turkeys. Do not use in female dairy cattle 20 months of age or older, including dry dairy cows. Injection site reactions and anaphylaxis/anaphylactoid reactions have been reported in cattle. Increxxa has a pre-slaughter withdrawal time of 18 days for cattle. See package insert for full prescribing information.

PRADALEX 

INDICATIONS: Pradalex is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in cattle intended for slaughter (beef calves 2 months of age and older, growing beef steers, growing beef heifers, and beef bulls intended for slaughter), and in cattle intended for breeding less than 1 year of age (replacement beef and dairy heifers less than 1 year of age and beef and dairy bulls less than 1 year of age). Not for use in cattle intended for breeding 1 year of age and older (replacement beef and dairy heifers 1 year of age and older, beef and dairy bulls 1 year of age and older, and beef and dairy cows), beef calves less than 2 months of age, dairy calves, and veal calves.

Important Safety Information (ISI)

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian and prohibits the extra-label use of this drug in food-producing animals. To ensure responsible antimicrobial drug use, use of pradofloxacin should be limited to treatment of bovine respiratory disease (BRD) in cattle only after consideration of other non-fluoroquinolone therapeutic options.

Not for use in humans. Keep out of reach of children. Avoid contact with eyes and skin. Individuals with a history of hypersensitivity to quinolones should avoid this product. Not for use in animals intended for breeding greater than 1 year of age. Not for use in beef calves less than 2 months of age, dairy calves and veal calves; a withdrawal period has not been established for this product in pre-ruminating calves. Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. Mild to moderate inflammatory changes of the injection site may be seen in cattle treated with Pradalex. Pradalex has a pre-slaughter withdrawal time of 4 days for cattle. See package insert for additional safety information.

RUMENSIN

CAUTION:

Consumption by unapproved species or feeding undiluted may be toxic or fatal. Do not feed to veal calves.

DIRECTIONS FOR USE:

Dairy Cows:

For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake):

Feeding Directions:

Total Mixed Rations (“complete feed”): Feed continuously to dry and lactating dairy cows a total mixed ration (“complete feed”) containing 11 to 22 g/ton monensin on a 100% dry matter basis.

Component Feeding Systems (including top dress): Feed continuously to dry and lactating dairy cows a Type C Medicated Feed containing 11 to 400 g/ton monensin. The Type C Medicated Feed must be fed in a minimum of 1 pound of feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows. This provides cows with similar amounts of monensin they would receive by consuming total mixed rations containing 11 to 22 g/ton monensin on a 100% dry matter basis.

Growing beef steers and heifers on pasture (stocker, feeder and slaughter) or in a dry lot and replacement beef and dairy heifers:

For increased rate of weight gain: Feed 50 to 200 mg/hd/day in at least 1.0 lb. of Type C Medicated Feed. Or, after the fifth day, feed 400 mg/hd/day every other day in 2.0 lbs. of Type C Medicated Feed. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis). Do not self-feed.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed at a rate to provide 0.14 to 0.42 mg/lb. of body weight/day, depending upon the severity of challenge, up to a maximum of 200 mg/hd/day. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis).

Type C free-choice medicated feeds: All Type C free-choice medicated feeds containing Rumensin must be manufactured according to an FDA-approved formula/specification. When using a formula/specification published in the Code of Federal Regulations (CFR), a Medicated Feed Mill license is not required. Use of Rumensin in a proprietary formula/specification not published in the CFR requires prior FDA approval and a Medicated Feed Mill License.

Do not use Titanium^® BRSV 3, Titanium^® 3 LP, Titanium^® 3, Titanium^® IBR LP and Titanium^® IBR in pregnant cows or in calves nursing pregnant cows. Abortions may result.

Agita, Assist, Clean-Up, Corathon, CyLence, Cydectin, Elector, Encore, Elector, Increxxa, Master Guard, Micotil, Neporex, Nuplura, Patriot, Permectrin, Pradalex, QuickBayt, Ravap, Rumensin, Scour Bos, Titanium, Vapona, Vira Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

Baytril 100 is sold by Elanco or its affiliates and is not a Bayer product. The Baytril trademark is owned by Bayer and used under license.

Bovaer® is a registered trademark of dsm-firmenich. Other company and product names are trademarks of their respective owners.